Pharmacology [bmod]
Efficacy [qlco]
Hypercholesterolaemia [dsyn]
Simvastatin [orch, phsu]
HMG-CoA reductase inhibitor [orch, phsu]
treatment [ftcn]
Patients [podg]
Hypercholesterolaemia [dsyn]
Simvastatin [orch, phsu]
reviewed [inpr]
Drugs [phsu]
Large [qnco]
Clinical Trials [resa]
confirmed [qlco]
Efficacy [qlco]
reductions [npop]
baseline [bodm]
Approximately [qlco]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
Triglycerides [bacs, lipd]
Patients [podg]
Primary hypercholesterolaemia [dsyn]
Receive [qlco]
Simvastatin [orch, phsu]
mg day [qnco]
High density lipoprotein cholesterol level [lbpr]
Increased [qnco]
Little NOS [cgab, dsyn]
Attenuation [acty]
serum lipid [lbpr]
Lipoprotein [aapp, bacs]
Occurred [acty]
Administration [ocac]
Simvastatin [orch, phsu]
Comparative Studies [inpr]
HMG-CoA Reductase Inhibitors [orch, phsu]
Lovastatin [orch, phsu]
Pravastatin [orch, phsu]
fluvastatin [orch, phsu]
Lacking [qlco]
Previous [tmco]
Simvastatin [orch, phsu]
reductions [npop]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
Simvastatin [orch, phsu]
Equal [qlco]
Dosages [qnco]
Lovastatin [orch, phsu]
Pravastatin [orch, phsu]
reductions [npop]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
Agent [chvf]
Lovastatin [orch, phsu]
Pravastatin [orch, phsu]
Administered [ftcn]
Daily [tmco]
Dosage [qnco]
Twice [inpr]
Simvastatin [orch, phsu]
fluvastatin [orch, phsu]
Administered [ftcn]
Daily [tmco]
Dosage [qnco]
Approximately [qlco]
times [tmco]
Simvastatin [orch, phsu]
General [spco]
Simvastatin [orch, phsu]
mg day [qnco]
effective [qlco]
Standard [qlco]
Dosages [qnco]
Bile Acid Sequestrants [phsu]
Fibrates [orch, phsu]
Probucol [orch, phsu]
lowering [spco]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
Fibrates [orch, phsu]
reductions [npop]
serum triglycerides [lbpr]
elevations [spco]
High density lipoprotein cholesterol level [lbpr]
Scandinavian [popg]
Simvastatin [orch, phsu]
Survival [acty]
Study [mnob]
4s [bpoc]
Large [qnco]
Secondary Prevention [topp]
Study [mnob]
Patients [podg]
coronary heart disease [dsyn]
Concomitant [tmco]
Hypercholesterolaemia [dsyn]
Simvastatin [orch, phsu]
mg day [qnco]
Reduced [qlco]
Mortality [qnco]
Primary Endpoint [irda]
Study [mnob]
Compared [acty]
placebo [topp]
Attribute [idcn]
Relative [famg]
reduction [npop]
coronary coronary [bpoc]
Mortality [qnco]
Morbidity [qnco]
Reduced [qlco]
Simvastatin [orch, phsu]
4s [bpoc]
Trial [resa]
TOLERABILITY [resa]
Profile [lbpr]
Simvastatin [orch, phsu]
APPEAR [qlco]
HMG-CoA Reductase Inhibitors [orch, phsu]
Frequently [tmco]
Reported [inpr]
adverse events [fndg]
Gastrointestinal disturbances [fndg]
Mild [qlco]
Frequently [tmco]
Cholestyramine [orch, phsu]
Simvastatin [orch, phsu]
effective [qlco]
Agent [chvf]
Available [ftcn]
treating [topp]
Patients [podg]
Hypercholesterolaemia [dsyn]
Efficacy [qlco]
TOLERABILITY [resa]
Profile [lbpr]
Simvastatin [orch, phsu]
For [qlco]
HMG-CoA Reductase Inhibitors [orch, phsu]
Fibrates [orch, phsu]
Bile Acid Sequestrants [phsu]
Therapeutic Efficacy [qlco]
Maintained [ftcn]
Administration [ocac]
Simvastatin [orch, phsu]
4s [bpoc]
Trial [resa]
Simvastatin [orch, phsu]
reduction [npop]
Mortality [qnco]
Lipid lowering agent [phsu]
Secondary Prevention [topp]
Profile [lbpr]
findings [ftcn]
Firmly [qlco]
Established [qlco]
Simvastatin [orch, phsu]
Line [spco]
Agent [chvf]
Cholesterol [bacs, strd]
lowering [spco]
therapy [ftcn]
